GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cuorips Inc (TSE:4894) » Definitions » ROCE %

Cuorips (TSE:4894) ROCE % : 0.00% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Cuorips ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cuorips's annualized ROCE % for the quarter that ended in Sep. 2024 was 0.00%.


Cuorips ROCE % Historical Data

The historical data trend for Cuorips's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cuorips ROCE % Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24
ROCE %
-6.93 -9.11 -12.14 -12.38

Cuorips Quarterly Data
Mar21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only -11.32 -10.27 -11.13 -8.41 -

Cuorips ROCE % Calculation

Cuorips's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=-588.487/( ( (3587.417 - 97.425) + (6184.738 - 166.015) )/ 2 )
=-588.487/( (3489.992+6018.723)/ 2 )
=-588.487/4754.3575
=-12.38 %

Cuorips's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Mar. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Mar. 2024 )(Q: Sep. 2024 )
=0/( ( (6184.738 - 166.015) + (5760.567 - 141.681) )/ 2 )
=0/( ( 6018.723 + 5618.886 )/ 2 )
=0/5818.8045
=0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cuorips  (TSE:4894) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Cuorips ROCE % Related Terms

Thank you for viewing the detailed overview of Cuorips's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cuorips Business Description

Traded in Other Exchanges
N/A
Address
3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.

Cuorips Headlines

No Headlines